Semaphorin3A: A potential therapeutic tool in immune-mediated diseases.
Eur J Rheumatol. 2018 Mar;5(1):58-61. doi: 10.5152/eurjrheum.2017.17076. Epub 2017 Dec 7.
Eur J Rheumatol. 2018.
PMID: 29657877
Free PMC article.
Review.